Overview

Cannabidiol for Anxiety

Status:
Withdrawn
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
This pilot trial seeks to investigate the effect of 25 mg full-spectrum CBD soft gel capsules (up to a total dosage of 100mg per day) on individuals with diagnosed anxiety. All participants will take CBD soft gel capsules for 12 weeks, and will be assessed at 6 weeks and 12 weeks post-enrollment using measures of anxiety, sleep and perception of change.
Phase:
Phase 2
Details
Lead Sponsor:
CB2 Insights
Collaborator:
Green Lotus Hemp
Treatments:
Cannabidiol
Epidiolex